ABL Bio Inc. (298380.KQ)

KRW 67200.0

(3.07%)

Revenue Summary of ABL Bio Inc.

ABL Bio Inc.'s latest annual revenue in 2023 was 65.54 Billion KRW , down -2.61% from previous year.
ABL Bio Inc.'s latest quarterly revenue in 2024 Q1 was 7.93 Billion KRW , down -0.84% from previous quarter.
ABL Bio Inc. reported a annual revenue of 67.3 Billion KRW in annual revenue 2022, up 1162.19% from previous year.
ABL Bio Inc. reported a annual revenue of 5.33 Billion KRW in annual revenue 2021, down -34.21% from previous year.
ABL Bio Inc. reported a quarterly revenue of 8.44 Billion KRW for 2024 Q2, up 6.36% from previous quarter.
ABL Bio Inc. reported a quarterly revenue of 65.54 Billion KRW for 2023 FY, down -2.61% from previous quarter.

Annual Revenue Chart of ABL Bio Inc. (2023 - 2016)

Historical Annual Revenue of ABL Bio Inc. (2023 - 2016)

Year	Revenue	Revenue Growth
2023	65.54 Billion KRW	-2.61%
2022	67.3 Billion KRW	1162.19%
2021	5.33 Billion KRW	-34.21%
2020	8.1 Billion KRW	103.17%
2019	3.98 Billion KRW	217.12%
2018	1.25 Billion KRW	1661.04%
2017	71.42 Million KRW	0.0%
2016	- KRW	0.0%

Year	Revenue	Revenue Growth
2024 Q1	7.93 Billion KRW	-0.84%
2024 Q2	8.44 Billion KRW	6.36%
2023 FY	65.54 Billion KRW	-2.61%
2023 Q4	8 Billion KRW	-6.6%
2023 Q3	8.57 Billion KRW	-0.23%
2023 Q2	8.59 Billion KRW	-78.73%
2023 Q1	40.38 Billion KRW	307.73%
2022 Q1	2.87 Billion KRW	382.1%
2022 FY	67.3 Billion KRW	1162.19%
2022 Q4	9.9 Billion KRW	-74.19%
2022 Q3	38.37 Billion KRW	137.79%
2022 Q2	16.13 Billion KRW	460.59%
2021 Q3	568.01 Million KRW	-75.82%
2021 Q2	2.34 Billion KRW	29.28%
2021 Q4	597.17 Million KRW	5.13%
2021 Q1	1.81 Billion KRW	0.0%
2021 FY	5.33 Billion KRW	-34.21%
2020 FY	8.1 Billion KRW	103.17%
2019 FY	3.98 Billion KRW	217.12%
2018 FY	1.25 Billion KRW	1661.04%
2017 FY	71.42 Million KRW	0.0%
2016 FY	- KRW	0.0%

Peer Revenue Comparison of ABL Bio Inc.

Name	Revenue	Revenue Difference
Sam Chun Dang Pharm. Co., Ltd	192.66 Billion KRW	65.979%
Hyundai Bioscience Co., Ltd.	9.48 Billion KRW	-591.324%
ST Pharm Co.,Ltd.	284.99 Billion KRW	77.0%
Cellid, Co., Ltd.	- KRW	-Infinity%